Table 3.
Logistic regression analysis of thyroid hormone levels with DR.
Characteristics | Groups | Number | Model 1 OR (95% CI) | P | Model 2 OR (95% CI) | P |
---|---|---|---|---|---|---|
TSH | <2.5 | 413 | Reference | Reference | ||
≥2.50 | 220 | 1.284 (0.919–1.794) | 0.143 | 0.917 (0.605–1.390) | 0.682 | |
FT3 | Q1 (<4.35) | 154 | Reference | Reference | ||
Q2 (4.35–4.70) | 159 | 0.563 (0.358–0.885) | 0.013 | 0.587 (0.340–1.012) | 0.055 | |
Q3 (4.70–5.08) | 160 | 0.378 (0.235–0.608) | <0.001 | 0.458 (0.258–0.813) | 0.008 | |
Q4 (≥5.08) | 160 | 0.238 (0.144–0.392) | <0.001 | 0.368 (0.201–0.673) | 0.001 | |
FT4 | Q1 (<14.98) | 157 | Reference | Reference | ||
Q2 (14.98–16.23) | 159 | 0.714 (0.455–1.120) | 0.143 | 0.712 (0.411–1.235) | 0.227 | |
Q3 (16.23–17.79) | 159 | 0.657 (0.418–1.035) | 0.070 | 0.738 (0.419–1.300) | 0.293 | |
Q4 (≥17.79) | 158 | 0.761 (0.485–1.193) | 0.234 | 1.166 (0.666–2.041) | 0.591 | |
TPO-Ab | <78 | 593 | Reference | Reference | ||
≥78 | 40 | 0.961 (0.496–1.861) | 0.905 | 0.979 (0.452–2.121) | 0.958 |
Model 1: crude model. Model 2: adjusted for age, duration of T2DM, gender, smoking, BMI, insulin medication, metformin medication, hypertension, HbA1c, TG, and TC.